HIV/AIDS Therapy
Emtricitabine is option for once-daily antiretroviral therapy
Published in Drug Week, April 2nd, 2004
According to recent research from Argentina, "Highly active antiretroviral therapy has resulted in a dramatic decline in morbidity and mortality among patients infected with HIV. Nevertheless, this success has to be considered in the context of the current challenges and needs in this field. Adherence, toxicity, potency, and resistance are still matters of intense research, which need to improve in order to overcome the current limitations of available drugs."
"Regarding needs, the improvement of convenience, tolerability, and pharmacokinetics run in parallel with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-04-02)
More Articles from Drug Week
- HIV/AIDS Proteomics
HIV Vif protein post-translationally modified by ubiquitin - HIV/AIDS Proteomics
Protease activity regulates Env-mediated membrane fusion - HIV/AIDS Proteomics
Tat from HIV subtype C has impaired chemotactic ability - HIV/AIDS RNA Research
Perinuclear HIV RNA release mediated by hRIP - HIV/AIDS RNA Studies
Antisense oligonucleotide scanning arrays reveal novel HIV leader RNA foldings - HIV/AIDS Therapy
Protease inhibitors can induce lactic acidosis - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
